Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: intraocular therapeutics - ImprimisRx

Drug Profile

Research programme: intraocular therapeutics - ImprimisRx

Alternative Names: Epinephrine/lidocaine; Go Dropless; IPI-140; Lidocaine/epinephrine; Lidocaine/phenylephrine combination; Lyophilized epinephrine combination; Moxifloxacin/triamcinolone; Shugarcaine combination; Triamcinolone/moxifloxacin; Triamcinolone/vancomycin; TriMox; TriMox/vancomycin; TriMoxi; TriMoxi/vancomycin; Vancomycin/moxifloxacin/triamcinolone

Latest Information Update: 14 Jan 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eye Care Northwest; Novel Drug Solutions
  • Developer ImprimisRx
  • Class Acetanilides; Azabicyclo compounds; Catecholamines; Cyclopropanes; Ethanolamines; Fluorinated steroids; Fluoroquinolones; Glucocorticoids; Glycopeptides; Piperidines; Pregnadienes; Pyrrolidines; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Postoperative infections; Postoperative inflammation

Most Recent Events

  • 31 Dec 2018 Imprimis Pharmaceuticals changed its name to Harrow Health and added all ophthalmology business to its subsidiary ImprimisRx
  • 18 Nov 2014 Discontinued - Preclinical for Postoperative infections (Prevention) and Postoperative inflammation (Prevention) in USA (Intraocular)
  • 18 Nov 2014 Discontinued - Preclinical for Postoperative inflammation (Prevention) in USA (Intraocular)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top